Burosumab
Burosumab (KRN23) is a human monoclonal antibody targeting fibroblast growth factor 23 (FGF23) for the treatment of cutaneous-skeletal hypophosphatemic syndrome (CSHS) and tumor-induced osteochondrosis.
Product Specifications
CAS Number
1610833-03-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
23899121 3x 1.0µg DNA
HRH2 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details MBS6333348-01 0.1 mL
PHF20L1, CT (PHF20L1, PHD finger protein 20-like protein 1) (MaxLight 405)
Sign In for Pricing
View Details MBS6333348-02 5x 0.1 mL
PHF20L1, CT (PHF20L1, PHD finger protein 20-like protein 1) (MaxLight 405)
Sign In for Pricing
View Details